Ranitidine reduced levodopa-induced dyskinesia in a rat model of Parkinson’s disease

BACKGROUND: Chronic administration of levodopa in Parkinson’s disease leads to debilitating involuntary movements, termed levodopa-induced dyskinesia (LID). The pathogenesis of LID is poorly understood. Previous research has shown that histamine H(2) receptors are highly expressed in the input (stri...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Guiyun, Yang, Xinxin, Wang, Xiaoying, Zhang, Zunsheng, Yue, Xuanye, Shi, Hongjuan, Shen, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872142/
https://www.ncbi.nlm.nih.gov/pubmed/24379672
http://dx.doi.org/10.2147/NDT.S54782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872142/
https://www.ncbi.nlm.nih.gov/pubmed/24379672
http://dx.doi.org/10.2147/NDT.S54782

Ejemplares similares